Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juncheng Wang

Showing results (101-110 of 250) with videos related to

Pageof 25
Sort By:
Journal of Hazardous Materials|June 27, 2017
Detection of okadaic acid (OA) using ELISA and colloidal gold immunoassay based on monoclonal antibodyRongzhi Wang, Linmao Zeng, Hang Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2020
Structure-function analysis of microRNA 3'-end trimming by NibblerWei Xie, Ivica Sowemimo, Rippei Hayashi, et al.
Oral Oncology|December 30, 2021
The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant siteJuncheng Wang, Yuxi Tian, Huimei Huang, et al.
Molecular Cell|February 24, 2022
Structural insights into DNMT5-mediated ATP-dependent high-fidelity epigenome maintenanceJuncheng Wang, Sandra Catania, Chongyuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
Hatchet ribozyme structure and implications for cleavage mechanismLuqian Zheng, Christoph Falschlunger, Kaiyi Huang, et al.
Journal of Gastroenterology|August 3, 2022
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysisQunfang Zhou, Xiaohui Wang, Ruixia Li, et al.
Journal of Gastroenterology|July 11, 2022
Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysisQunfang Zhou, Xiaohui Wang, Ruixia Li, et al.
Biotechnology Letters|November 30, 2012
Cytosolic protection against ultraviolet induced DNA damage by blueberry anthocyanins and anthocyanidins in hepatocarcinoma HepG2 cellsWei Liu, Xiangyi Lu, Guangyang He, et al.
Journal of Cancer Research and Clinical Oncology|June 25, 2022
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world studyJinbin Chen, Peiyao Xiong, Man Nie, et al.
Journal of Hepatocellular Carcinoma|December 9, 2020
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 ImmunotherapyXuqi Sun, Dandan Hu, Zhoutian Yang, et al.
Pageof 25

Showing results (101-110 of 250) with videos related to

Sort By:
Pageof 25
Journal of Hazardous Materials|June 27, 2017
Detection of okadaic acid (OA) using ELISA and colloidal gold immunoassay based on monoclonal antibodyRongzhi Wang, Linmao Zeng, Hang Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2020
Structure-function analysis of microRNA 3'-end trimming by NibblerWei Xie, Ivica Sowemimo, Rippei Hayashi, et al.
Oral Oncology|December 30, 2021
The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant siteJuncheng Wang, Yuxi Tian, Huimei Huang, et al.
Molecular Cell|February 24, 2022
Structural insights into DNMT5-mediated ATP-dependent high-fidelity epigenome maintenanceJuncheng Wang, Sandra Catania, Chongyuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
Hatchet ribozyme structure and implications for cleavage mechanismLuqian Zheng, Christoph Falschlunger, Kaiyi Huang, et al.
Journal of Gastroenterology|August 3, 2022
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysisQunfang Zhou, Xiaohui Wang, Ruixia Li, et al.
Journal of Gastroenterology|July 11, 2022
Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysisQunfang Zhou, Xiaohui Wang, Ruixia Li, et al.
Biotechnology Letters|November 30, 2012
Cytosolic protection against ultraviolet induced DNA damage by blueberry anthocyanins and anthocyanidins in hepatocarcinoma HepG2 cellsWei Liu, Xiangyi Lu, Guangyang He, et al.
Journal of Cancer Research and Clinical Oncology|June 25, 2022
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world studyJinbin Chen, Peiyao Xiong, Man Nie, et al.
Journal of Hepatocellular Carcinoma|December 9, 2020
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 ImmunotherapyXuqi Sun, Dandan Hu, Zhoutian Yang, et al.
Pageof 25